TMCnet News

Cool & homogeneous: Single Use Support introduces product innovation
[January 19, 2023]

Cool & homogeneous: Single Use Support introduces product innovation

KUFSTEIN, Austria, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Emerging process solution provider Single Use Support has launched RoSS.PADL, an unprecedented platform system for standardizing homogenization and cooling of liquid pharmaceuticals.

RoSS.PADL optimizes fluid homogeneity through massaging and cooling single-use bags of any size. It ensures uniformity of the entire production batch with cGMP-compliant automation prior to dispensing into smaller single-use bioprocess containers. The seamless integration of this platform adds a reproducible and reliable step toward end-to-end fluid management processes. It eliminates the need for human intervention and with it the risk of single-use bag handling errors.

Newly automated process step

Bernhard Schlichtner, Chief Commercial Officer at Single Use Support, confirms several pre-orders for RoSS.PADL. “The combination of homogenization and cooling between 2°C and 8°C (35.6°F and 46.4°F) is unique and supports the resolution of increased aggregation of biologics and cells, e.g., during cell suspension. It elimintes the need for small mixing bags with impellers or manual intervention and advances the movement of liquids in a controlled manner during the aseptic filling process.” The single-use-bag-agnostic platform system maintains a closed system and simplifies the fluid management process.

RoSS.PADL is a platform to standardize cooling of your single-use bag whilst gently massaging it to ensure a homogenous mixture of your substance. With the RoSS.PADL platform, multiple cooling and massaging mechanisms can be placed side by side to scale-up with one control system.

With Single Use Support’s modular process solutions for sterile filling–draining, freezing–thawing and its protective solutions that cover the entire storage and shipment processes, the homogenizing system optimizes the fluid management of high-value liquid drug substances.

More about RoSS.PADL:

Press contact

Michael Eder
[email protected]

A photo accompanying this announcement is available at

Primary Logo

[ Back To's Homepage ]